ASX - By Stock
|
IR1 |
Re:
Ann: Board Resignations
|
|
zedcorp
|
39 |
10K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
39
|
10K
|
1
|
|
ASX - By Stock
|
LKE |
Re:
Ann: Trading Halt
|
|
zedcorp
|
283 |
78K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
283
|
78K
|
1
|
|
ASX - By Stock
|
LKE |
Re:
Ann: Trading Halt
|
|
zedcorp
|
283 |
78K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
283
|
78K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
zedcorp
|
422 |
188K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
422
|
188K
|
4
|
|
ASX - By Stock
|
EXR |
Re:
Ann: Significant Increase in Prospective Resources
|
|
zedcorp
|
61 |
20K |
12 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
61
|
20K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
zedcorp
|
316 |
159K |
14 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
159K
|
14
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
zedcorp
|
1.6K |
823K |
8 |
06/02/24 |
06/02/24 |
Charts
|
1.6K
|
823K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
zedcorp
|
91 |
30K |
25 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
91
|
30K
|
25
|
|
ASX - By Stock
|
LLL |
Re:
Ann: US$65m for 5% sale of Goulamina and Continued Suspension
|
|
zedcorp
|
394 |
124K |
11 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
394
|
124K
|
11
|
|
ASX - By Stock
|
LLL |
Re:
Ann: US$65m for 5% sale of Goulamina and Continued Suspension
|
|
zedcorp
|
394 |
124K |
13 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
394
|
124K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Katelin’s Turn is HERE!!!
|
|
zedcorp
|
211 |
108K |
50 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
211
|
108K
|
50
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
zedcorp
|
9.9K |
4.4M |
50 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
50
|
|
ASX - By Stock
|
LLL |
Re:
General Discussion
|
|
zedcorp
|
10K |
3.5M |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
10K
|
3.5M
|
8
|
|
ASX - By Stock
|
LLL |
Re:
Ann: US$65m for 5% sale of Goulamina and Continued Suspension
|
|
zedcorp
|
394 |
124K |
24 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
394
|
124K
|
24
|
|
ASX - By Stock
|
LLL |
Re:
Ann: US$65m for 5% sale of Goulamina and Continued Suspension
|
|
zedcorp
|
394 |
124K |
0 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
394
|
124K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
zedcorp
|
121 |
52K |
2 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
121
|
52K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
zedcorp
|
48 |
27K |
24 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
48
|
27K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
zedcorp
|
48 |
27K |
7 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
48
|
27K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
zedcorp
|
48 |
27K |
1 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
48
|
27K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
zedcorp
|
48 |
27K |
5 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
48
|
27K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
zedcorp
|
48 |
27K |
3 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
48
|
27K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
zedcorp
|
166 |
75K |
3 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
zedcorp
|
166 |
75K |
29 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
zedcorp
|
166 |
75K |
19 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
zedcorp
|
9.9K |
4.4M |
10 |
24/12/23 |
24/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
zedcorp
|
9.9K |
4.4M |
28 |
24/12/23 |
24/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
2 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
20 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
315
|
155K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
25 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
14 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
6 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
6 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
1 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
0 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
2 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
zedcorp
|
315 |
155K |
29 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
zedcorp
|
946 |
470K |
4 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
946
|
470K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
zedcorp
|
9.9K |
4.4M |
8 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Rollout
|
|
zedcorp
|
128 |
63K |
22 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
128
|
63K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Rollout
|
|
zedcorp
|
128 |
63K |
12 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
128
|
63K
|
12
|
|
ASX - By Stock
|
LLL |
Re:
Ann: Continued Ganfeng Support - First Funds Received under EIA
|
|
zedcorp
|
66 |
35K |
24 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
66
|
35K
|
24
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
zedcorp
|
209 |
75K |
2 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
75K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
zedcorp
|
92 |
40K |
22 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
92
|
40K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
zedcorp
|
221 |
95K |
7 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
221
|
95K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
zedcorp
|
221 |
95K |
7 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
221
|
95K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
zedcorp
|
221 |
95K |
8 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
221
|
95K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
the game is ON
|
|
zedcorp
|
123 |
61K |
3 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
123
|
61K
|
3
|
|
ASX - By Stock
|
IVZ |
Re:
President Mnangagwa is back in Zimbabwe
|
|
zedcorp
|
14 |
4.2K |
5 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
14
|
4.2K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Feedback
|
|
zedcorp
|
47 |
22K |
41 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
47
|
22K
|
41
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
zedcorp
|
9.9K |
4.4M |
5 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
5
|
|